The development of COVID-19 treatment

被引:118
|
作者
Yuan, Yongliang [1 ]
Jiao, Baihai [2 ]
Qu, Lili [3 ]
Yang, Duomeng [3 ]
Liu, Ruijuan [1 ]
机构
[1] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Univ Connecticut, Sch Med, Dept Med, Div Nephrol,Hlth Ctr, Farmington, CT USA
[3] Univ Connecticut, Sch Med, Dept Immunol, Hlth Ctr, Farmington, CT 06269 USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
COVID-19; treatments; antiviral agents; neutralizing antibody therapy; Janus kinase inhibitors; JAK-STAT PATHWAY; OPEN-LABEL; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; RUXOLITINIB; STANDARD; MULTICENTER; FAVIPIRAVIR; TOFACITINIB; COMBINATION;
D O I
10.3389/fimmu.2023.1125246
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest worldwide public health threat of this century. Recent studies have unraveled numerous mysteries of SARS-CoV-2 pathogenesis and thus largely improved the studies of COVID-19 vaccines and therapeutic strategies. However, important questions remain regarding its therapy. In this review, the recent research advances on COVID-19 mechanism are quickly summarized. We mainly discuss current therapy strategies for COVID-19, with an emphasis on antiviral agents, neutralizing antibody therapies, Janus kinase inhibitors, and steroids. When necessary, specific mechanisms and the history of therapy are present, and representative strategies are described in detail. Finally, we discuss key outstanding questions regarding future directions of the development of COVID-19 treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Pharmacological treatment of COVID-19: an opinion paper
    Garcia-Lledo, A.
    Gomez-Pavon, J.
    Gonzalez del Castillo, J.
    Hernandez-Sampelayo, T.
    Martin-Delgado, M. C.
    Martin Sanchez, F. J.
    Martinez-Selles, M.
    Molero Garcia, J. M.
    Moreno Guillen, S.
    Rodriguez-Artalejo, F. J.
    Ruiz-Galiana, J.
    Canton, R.
    De Lucas Ramos, P.
    Garcia-Botella, A.
    Bouza, E.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 (02) : 115 - 130
  • [2] Evaluation of favipiravir in the treatment of COVID-19 based on the real-world
    Deng, Weishang
    Yang, Changyuan
    Yang, Sensen
    Chen, Haitao
    Qiu, Zhikun
    Chen, Jisheng
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (04) : 555 - 565
  • [3] COVID-19 Antiviral and Treatment Candidates: Current Status
    Espano, Erica
    Kim, Dajung
    Kim, Jiyeon
    Park, Song-Kyu
    Kim, Jeong-Ki
    IMMUNE NETWORK, 2021, 21 (01) : 1 - 24
  • [4] JAK inhibition as a new treatment strategy for patients with COVID-19
    Huang, Jin
    Zhou, Chi
    Deng, Jinniu
    Zhou, Jianfeng
    BIOCHEMICAL PHARMACOLOGY, 2022, 202
  • [5] ISTH guidelines for antithrombotic treatment in COVID-19
    Schulman, Sam
    Sholzberg, Michelle
    Spyropoulos, Alex C.
    Zarychanski, Ryan
    Resnick, Helaine E.
    Bradbury, Charlotte A.
    Broxmeyer, Lisa
    Connors, Jean Marie
    Falanga, Anna
    Iba, Toshiaki
    Kaatz, Scott
    Levy, Jerrold H.
    Middeldorp, Saskia
    Minichiello, Tracy
    Ramacciotti, Eduardo
    Samama, Charles Marc
    Thachil, Jecko
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (10) : 2214 - 2225
  • [6] Therapeutic Development in COVID-19
    Yang, Chan
    Huang, Yuan
    Liu, Shuwen
    CORONAVIRUS DISEASE - COVID-19, 2021, 1318 : 435 - 448
  • [7] Treatment for COVID-19: An overview
    Stasi, Cristina
    Fallani, Silvia
    Voller, Fabio
    Silvestri, Caterina
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 889
  • [8] Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposed for Treatment of COVID-19
    Tandon, Nitin
    Luxami, Vijay
    Tandon, Runjhun
    Paul, Kamaldeep
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (21) : 2752 - 2768
  • [9] Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce
    White, Heath
    McDonald, Steve J.
    Barber, Bridget
    Davis, Joshua
    Burr, Lucy
    Nair, Priya
    Mukherjee, Sutapa
    Tendal, Britta
    Elliott, Julian
    McGloughlin, Steven
    Turner, Tari
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (07) : 368 - 378
  • [10] Anticoagulant Treatment in Severe ARDS COVID-19 Patients
    Ceccato, Adrian
    Camprubi-Rimblas, Marta
    Campana-Duel, Elena
    Areny-Balaguero, Aina
    Morales-Quinteros, Luis
    Artigas, Antonio
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)